Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Mitochondrial disease

Gene: ATP5A1

Green List (high evidence)

ATP5A1 (ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle)
EnsemblGeneIds (GRCh38): ENSG00000152234
EnsemblGeneIds (GRCh37): ENSG00000152234
OMIM: 164360, Gene2Phenotype
ATP5A1 is in 5 panels

3 reviews

Rylee Peters (Victorian Clinical Genetics Services)

Green List (high evidence)

PMID: 40672495: 6x de novo individuals - 4 variants p.Arg182Gln, p.Ser346Phe, p.Pro331Leu, and p.Leu109Ser - with complex but overlapping neurological phenotypes including developmental delays, intellectual disability, pyramidal tract dysfunction, and dystonia.

In vivo functional studies in C. elegans were performed for three of the variants, showing growth defects and disruption of mitochondrial function (measured by mitochondrial stress). Authors suggest a dominant negative mechanism.
Created: 10 Sep 2025, 3:29 a.m. | Last Modified: 10 Sep 2025, 3:29 a.m.
Panel Version: 0.998

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A (MIM#620358)

Publications

Naomi Baker (Victorian Clinical Genetics Services)

I don't know

PMID: 34954817 reports three individuals with de novo monoallelic missense variants. One of these is the recurrent p.(Arg207His) variant while the other two variants are different substitutions. The three patients presented with a variable phenotypes: (1) a 14-year-old girl who presented during the first few months of life with developmental delay, failure-to-thrive, and lactic acidosis. She recovered and had no persistent neurologic phenotype; (2) a 17-year-old boy with psychomotor delay, intellectual disability, ataxia, spastic paraparesis, and dystonia; (3) a 12-year-old girl with psychomotor retardation, spastic tetraparesis, generalized dystonia, absent speech, swallowing problems, and increased blood lactate concentrations. Enzymatic investigations of muscle tissue from patient 1 showed a decrease in ATPase activity.
Created: 7 Jan 2022, 5:58 a.m. | Last Modified: 7 Jan 2022, 5:58 a.m.
Panel Version: 0.685
PMID: 34483339; an identical de novo variant identified in 3 unrelated neonates presenting with feeding intolerance, failure to thrive, hyperammonemia and lactic acidemia. Although subclinical biochemical abnormalities persisted in each case, the major clinical symptoms appeared to remit by late infancy in all cases.
Created: 3 Dec 2021, 3:42 a.m. | Last Modified: 3 Dec 2021, 3:42 a.m.
Panel Version: 0.674

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
feeding intolerance, failure to thrive, hyperammonemia, lactic acidemia

Publications

Zornitza Stark (Victorian Clinical Genetics Services)

Red List (low evidence)

Comment when marking as ready: HGNC approved name: ATP5F1A
Created: 3 May 2020, 3:34 a.m. | Last Modified: 3 May 2020, 3:34 a.m.
Panel Version: 0.442
One family described with each of these mitochondrial conditions. Evidence for bi-allelic disease is limited. In one of the families, PMID 23599390, only a paternally inherited variant was identified, maternal variant presumed based on functional studies but not actually identified. In the other family, PMID 23596069, the variant identified is a homozygous missense.
Created: 7 Jan 2020, 8:10 a.m. | Last Modified: 10 Sep 2025, 10:43 p.m.
Panel Version: 0.999

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
  • Australian Genomics Health Alliance Mitochondrial Flagship
Phenotypes
  • Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A (MIM#620358)
  • Combined oxidative phosphorylation deficiency 22 616045
  • Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228
  • Mitochondrial disorder, autosomal dominant
Tags
new gene name
OMIM
164360
Clinvar variants
Variants in ATP5A1
Penetrance
None
Publications
Panels with this gene

History Filter Activity

10 Sep 2025, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ATP5A1 were changed from Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228; Mitochondrial disorder, autosomal dominant to Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A (MIM#620358); Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228; Mitochondrial disorder, autosomal dominant

10 Sep 2025, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ATP5A1 were set to 23599390; 34483339

10 Sep 2025, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: ATP5A1 was changed from BOTH monoallelic and biallelic, autosomal or pseudoautosomal to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

10 Sep 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: atp5a1 has been classified as Green List (High Evidence).

3 Dec 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ATP5A1 were changed from Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228; Mitochondrial disorder, autosomal dominant to Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228; Mitochondrial disorder, autosomal dominant

3 Dec 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ATP5A1 were changed from Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228 to Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228; Mitochondrial disorder, autosomal dominant

3 Dec 2021, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ATP5A1 were set to 23599390

3 Dec 2021, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: ATP5A1 was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

3 May 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: atp5a1 has been classified as Amber List (Moderate Evidence).

3 May 2020, Gel status: 2

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag new gene name tag was added to gene: ATP5A1.

18 Mar 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: atp5a1 has been classified as Amber List (Moderate Evidence).

18 Mar 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ATP5A1 were changed from to Combined oxidative phosphorylation deficiency 22 616045; Mitochondrial complex V (ATP synthase) deficiency nuclear type 4, 615228

18 Mar 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ATP5A1 were set to

7 Jan 2020, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: ATP5A1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

7 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: atp5a1 has been classified as Amber List (Moderate Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: ATP5A1 was added gene: ATP5A1 was added to Mitochondrial_AGHA_VCGS. Sources: Expert Review Green,Australian Genomics Health Alliance Mitochondrial Flagship,Victorian Clinical Genetics Services Mode of inheritance for gene: ATP5A1 was set to Unknown